Ja Young Seo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ja Young Seo has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Jeong-Yeal Ahn
Department of Laboratory Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea
5 shared publications - Pil-Whan Park
Department of Laboratory Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea
3 shared publications - Yiel Hea Seo
Department of Laboratory Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon 21565, Republic of Korea
3 shared publications - Daewon Kim
Department of Laboratory Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon 21565, Republic of Korea
2 shared publications - Hwan Tae Lee
Department of Laboratory Medicine, Gachon University Gil Medical Center, Incheon, Korea
2 shared publications - Bhumsuk Keam
Department of Internal Medicine Seoul National University Hospital Seoul Republic of Korea
1 shared publication
Latest Publications
- Open Access
Evaluation of Marker Gene-Based In Silico Antimicrobial Resistance Prediction Tools
The monitoring and surveillance of antimicrobial resistance (AMR) is an important procedure in clinical patient management and epidemiological public health. Conventionally, culture-based tools such as disk diffusion methods or broth dilution methods for antibiotic susceptibility tests are used. While culture-independent approaches, such as PICRUSt2, Tax4Fun, or MicFunPred, have recently been tried based on predictive functional profiling using the 16S rRNA marker gene, evaluations of AMR tools are scarce. A total of 20 E. coli strains (Carbapenem-resistant (CRE) positive: 10, CRE negative: 10) were used. The AMR phenotype was based on Vitek2 (bioMerieux). DNA was extracted from the 20 strains, and 16S rRNA (V3-V4 region) and shotgun sequencing was carried out. The bioinformatic pipelines were QIIM2 for 16S rRNA and MetaPhlAn4 for shotgun. The functional prediction tools were PICRUSt2, Tax4Fun, and MicFunPred for 16S rRNA and AMRFinderPlus for shotgun. The presence/absence of 23 KEGG numbers regarding AMR in PICRUSt2, Tax4Fun, and MicFunPred were compared to shotgun AMR profiles. The F1 scores were calculated according to each 16S marker gene-based prediction tool using a confusion matrix. A total of 12 classes of antibiotics, including carbapenem, were analyzed. The F1 scores of 16S predictive functional profilers regarding AMR were 0.22 for Tax4Fun, 0.12 for PICRUSt2, and 0.08 for MicFunPred. While Tax4Fun showed the highest F1 score of the three 16S predictive functional profilers, the F1 scores were generally low. Our study highlights the necessity of integrating specialized AMR databases and improving algorithmic approaches to achieve meaningful accuracy in resistance prediction.
Open AccessEvaluation of Marker Gene-Based In Silico Antimicrobial Resistance Prediction Tools
The monitoring and surveillance of antimicrobial resistance (AMR) is an important procedure in clinical patient management and epidemiological public health. Conventionally, culture-based tools such as disk diffusion methods or broth dilution methods for antibiotic susceptibility tests are used. While culture-independent approaches, such as PICRUSt2, Tax4Fun, or MicFunPred, have recently been tried based on predictive functional profiling using the 16S rRNA marker gene, evaluations of AMR tools are scarce. A total of 20 E. coli strains (Carbapenem-resistant (CRE) positive: 10, CRE negative: 10) were used. The AMR phenotype was based on Vitek2 (bioMerieux). DNA was extracted from the 20 strains, and 16S rRNA (V3-V4 region) and shotgun sequencing was carried out. The bioinformatic pipelines were QIIM2 for 16S rRNA and MetaPhlAn4 for shotgun. The functional prediction tools were PICRUSt2, Tax4Fun, and MicFunPred for 16S rRNA and AMRFinderPlus for shotgun. The presence/absence of 23 KEGG numbers regarding AMR in PICRUSt2, Tax4Fun, and MicFunPred were compared to shotgun AMR profiles. The F1 scores were calculated according to each 16S marker gene-based prediction tool using a confusion matrix. A total of 12 classes of antibiotics, including carbapenem, were analyzed. The F1 scores of 16S predictive functional profilers regarding AMR were 0.22 for Tax4Fun, 0.12 for PICRUSt2, and 0.08 for MicFunPred. While Tax4Fun showed the highest F1 score of the three 16S predictive functional profilers, the F1 scores were generally low. Our study highlights the necessity of integrating specialized AMR databases and improving algorithmic approaches to achieve meaningful accuracy in resistance prediction.
- 20 December 2023
- Published by The Korean Society of Clinical Microbiology in Annals of Clinical Microbiology
- Vol. 26 (4) , 147-157
Analysis of blood culture data at a university hospital: bacterial distribution and cumulative antimicrobial resistance (2016–2020)
Background: The distribution of bacteria isolated from bloodstream infections and cumulative antimicrobial susceptibility data are the basis for empirical decisions regarding antibiotics as an initial treatment. Therefore, it is important to consistently collect blood culture results of individual patients and analyze them correctly. Methods: The blood culture results of patients at Gachon University Gil Medical Center from 2016 to 2020 were analyzed retrospectively to determine the bacterial distributions and antibiotic resistance patterns. Duplicates were eliminated by including only the first isolate of each species per patient. Results: Escherichia coli (27.1%) was the most commonly isolated bacterium from blood cultures, followed by Klebsiella pneumoniae (10.1%) and Staphylococcus aureus (8.6%). The methicillin resistance rate of S. aureus was 49.2%, and the vancomycin resistance rate of Enterococcus faecium was 39.5%; with no significant changes over the study period. The cefotaxime, ciprofloxacin, and ertapenem resistance rates of E. coli were 35.0%, 46.8%, and 0.7%, respectively. Seventeen carbapenem-resistant E. coli strains were isolated, of which 11 produced carbapenemase. The cefotaxime, ciprofloxacin, and ertapenem resistance rates of K. pneumoniae were 29.5%, 31.7%, and 5.4%, respectively. Forty-eight carbapenem-resistant K. pneumoniae strains were isolated, of which 37 produced carbapenemase. The imipenem resistance rates of Acinetobacter baumannii and Pseudomonas aeruginosa were 72.3% and 23.4%, respectively. Conclusion: In the blood culture results from 2016 to 2020, the isolation frequency of E. coli, K. pneumoniae, and E. faecium showed an increasing trend, whereas that of S. aureus was stable. Over the 5 year study period, the ciprofloxacin resistance rate of E. coli and P. aeruginosa and ampicillin/sulbactam resistance rate of A. baumannii significantly increased.
- 20 December 2023
- Published by The Korean Society of Clinical Microbiology in Annals of Clinical Microbiology
- Vol. 26 (4) , 147-157
Analysis of blood culture data at a university hospital: bacterial distribution and cumulative antimicrobial resistance (2016–2020)
Background: The distribution of bacteria isolated from bloodstream infections and cumulative antimicrobial susceptibility data are the basis for empirical decisions regarding antibiotics as an initial treatment. Therefore, it is important to consistently collect blood culture results of individual patients and analyze them correctly. Methods: The blood culture results of patients at Gachon University Gil Medical Center from 2016 to 2020 were analyzed retrospectively to determine the bacterial distributions and antibiotic resistance patterns. Duplicates were eliminated by including only the first isolate of each species per patient. Results: Escherichia coli (27.1%) was the most commonly isolated bacterium from blood cultures, followed by Klebsiella pneumoniae (10.1%) and Staphylococcus aureus (8.6%). The methicillin resistance rate of S. aureus was 49.2%, and the vancomycin resistance rate of Enterococcus faecium was 39.5%; with no significant changes over the study period. The cefotaxime, ciprofloxacin, and ertapenem resistance rates of E. coli were 35.0%, 46.8%, and 0.7%, respectively. Seventeen carbapenem-resistant E. coli strains were isolated, of which 11 produced carbapenemase. The cefotaxime, ciprofloxacin, and ertapenem resistance rates of K. pneumoniae were 29.5%, 31.7%, and 5.4%, respectively. Forty-eight carbapenem-resistant K. pneumoniae strains were isolated, of which 37 produced carbapenemase. The imipenem resistance rates of Acinetobacter baumannii and Pseudomonas aeruginosa were 72.3% and 23.4%, respectively. Conclusion: In the blood culture results from 2016 to 2020, the isolation frequency of E. coli, K. pneumoniae, and E. faecium showed an increasing trend, whereas that of S. aureus was stable. Over the 5 year study period, the ciprofloxacin resistance rate of E. coli and P. aeruginosa and ampicillin/sulbactam resistance rate of A. baumannii significantly increased.
- 2 February 2023
- Published by Oxford University Press (OUP) in Laboratory Medicine
- Vol. 54 (5) , 495-501
Short-Term (6 Weeks) Experience of a Modular Workcell for Hemostasis Testing Including an Intelligent Data Manager at a Tertiary Care Hospital
Objective: Modular workcells could be a better solution than total laboratory automation (TLA) in hemostasis laboratories. Here, we evaluated the impact of implementing a modular workcell (HemoCell) with an intelligent data management facility (HemoHub). Methods: We compared the turnaround times (TATs), numbers of rerun samples, and rerun times pre- and postimplementation of the HemoCell at Gil Medical Center. Prothrombin time (PT), activated partial thromboplastin time (aPTT), D-dimer, and fibrinogen were evaluated. Results: The TAT standard deviations (SDs) and maximum TAT values decreased after HemoCell implementation, although the mean TATs for PT, aPTT, and D-dimer were increased. Numbers of rerun samples were increased (18.1/day vs 44.7/day). However, rerun times were reduced, and SDs were decreased during the post-HemoCell period compared with pre-HemoCell. Additionally, technologists needed smaller working space and less labor. Conclusion: The modular workcell could improve quality and efficiency by providing more consistent TATs and shorter rerun times in the hemostasis laboratory.
- 2 February 2023
- Published by Oxford University Press (OUP) in Laboratory Medicine
- Vol. 54 (5) , 495-501
Short-Term (6 Weeks) Experience of a Modular Workcell for Hemostasis Testing Including an Intelligent Data Manager at a Tertiary Care Hospital
Objective: Modular workcells could be a better solution than total laboratory automation (TLA) in hemostasis laboratories. Here, we evaluated the impact of implementing a modular workcell (HemoCell) with an intelligent data management facility (HemoHub). Methods: We compared the turnaround times (TATs), numbers of rerun samples, and rerun times pre- and postimplementation of the HemoCell at Gil Medical Center. Prothrombin time (PT), activated partial thromboplastin time (aPTT), D-dimer, and fibrinogen were evaluated. Results: The TAT standard deviations (SDs) and maximum TAT values decreased after HemoCell implementation, although the mean TATs for PT, aPTT, and D-dimer were increased. Numbers of rerun samples were increased (18.1/day vs 44.7/day). However, rerun times were reduced, and SDs were decreased during the post-HemoCell period compared with pre-HemoCell. Additionally, technologists needed smaller working space and less labor. Conclusion: The modular workcell could improve quality and efficiency by providing more consistent TATs and shorter rerun times in the hemostasis laboratory.
- Open Access
- 16 May 2022
- Published by Korean Society of Pediatric Endocrinology in Annals of Pediatric Endocrinology & Metabolism
- Vol. 28 (2) , 149-154
A case of maturity-onset diabetes of the young type 4 in Korea
Maturity-onset diabetes of the young (MODY) is a rare, autosomal dominant disease characterized by non-ketogenic diabetes mellitus (DM). MODY type 4, caused by PDX1 mutation, is a very rare subtype of MODY, especially in Korea. We report a case of a 10-year-old, nonobese girl with a family history of type 2 DM. After diagnosis, the patient’s serum glucose level was well controlled using metformin monotherapy; however, the glycated hemoglobin level increased to 9.0% approximately 2 years after treatment. No obesity or lifestyle problems were observed, and serum fasting C-peptide level was within the normal range. Furthermore, no islet-related autoantibodies were detected. A genetic screening for MODY using a next-generation sequencing panel was performed, and a likely heterozygous pathogenic PDX1 mutation (p.Gly246ArgfsTer21) was identified. The PDX1 variant was not detected in her mother, implying that the mutation had arisen de novo in the proband. She was prescribed insulin degludec in addition to metformin therapy, which improved her hyperglycemia. This report presents a novel MODY type 4 phenotype and highlights the importance of genetic screening in patients with MODY characteristics.
- 16 May 2022
- Published by Korean Society of Pediatric Endocrinology in Annals of Pediatric Endocrinology & Metabolism
- Vol. 28 (2) , 149-154
Open AccessA case of maturity-onset diabetes of the young type 4 in Korea
Maturity-onset diabetes of the young (MODY) is a rare, autosomal dominant disease characterized by non-ketogenic diabetes mellitus (DM). MODY type 4, caused by PDX1 mutation, is a very rare subtype of MODY, especially in Korea. We report a case of a 10-year-old, nonobese girl with a family history of type 2 DM. After diagnosis, the patient’s serum glucose level was well controlled using metformin monotherapy; however, the glycated hemoglobin level increased to 9.0% approximately 2 years after treatment. No obesity or lifestyle problems were observed, and serum fasting C-peptide level was within the normal range. Furthermore, no islet-related autoantibodies were detected. A genetic screening for MODY using a next-generation sequencing panel was performed, and a likely heterozygous pathogenic PDX1 mutation (p.Gly246ArgfsTer21) was identified. The PDX1 variant was not detected in her mother, implying that the mutation had arisen de novo in the proband. She was prescribed insulin degludec in addition to metformin therapy, which improved her hyperglycemia. This report presents a novel MODY type 4 phenotype and highlights the importance of genetic screening in patients with MODY characteristics.
- Open Access
- 21 August 2021
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 27 (31) , 5247-5258
Tailored eradication strategy vs concomitant therapy for Helicobacter pylori eradication treatment in Korean patients
Tailored eradication strategy vs concomitant therapy for Helicobacter pylori eradication treatment in Korean patients
- 21 August 2021
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 27 (31) , 5247-5258
Open AccessTailored eradication strategy vs concomitant therapy for Helicobacter pylori eradication treatment in Korean patients
Tailored eradication strategy vs concomitant therapy for Helicobacter pylori eradication treatment in Korean patients
- Open Access
- 1 March 2021
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 41 (2) , 207-213
Genotypic and Phenotypic Characteristics of Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Korean Patients
Ja Young Seo, M.D., Ph.D., Jeong-Yeal Ahn, M.D., Ph.D., Bhumsuk Keam, M.D., Ph.D., Miso Kim, M.D., Shinkyo Yoon, M.D., Ph.D., Jae Lyun Lee, M.D., Ph.D., Kwonoh Park, M.D., Ph.D., and Inkeun Park, M.D., Ph.D.. Ann Lab Med 2021;41:207-13. https://doi.org/10.3343/alm.2021.41.2.207
- 1 March 2021
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 41 (2) , 207-213
Open AccessGenotypic and Phenotypic Characteristics of Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Korean Patients
Ja Young Seo, M.D., Ph.D., Jeong-Yeal Ahn, M.D., Ph.D., Bhumsuk Keam, M.D., Ph.D., Miso Kim, M.D., Shinkyo Yoon, M.D., Ph.D., Jae Lyun Lee, M.D., Ph.D., Kwonoh Park, M.D., Ph.D., and Inkeun Park, M.D., Ph.D.. Ann Lab Med 2021;41:207-13. https://doi.org/10.3343/alm.2021.41.2.207
- Open Access
- 1 January 2020
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 40 (1) , 7-14
Performance of Copeptin for Early Diagnosis of Acute Myocardial Infarction in an Emergency Department Setting
Jeong JH, et al. Ann Lab Med. 2020 Jan;40(1):7-14. https://doi.org/10.3343/alm.2020.40.1.7
- 1 January 2020
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 40 (1) , 7-14
Open AccessPerformance of Copeptin for Early Diagnosis of Acute Myocardial Infarction in an Emergency Department Setting
Jeong JH, et al. Ann Lab Med. 2020 Jan;40(1):7-14. https://doi.org/10.3343/alm.2020.40.1.7